Neoplasms, Glandular and Epithelial  >>  Unituxin (dinutuximab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Unituxin (dinutuximab) / United Therapeutics Corp, Ohara Pharma
NCT01592045: ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma

Completed
1/2
28
US
ch14.18 -NCI, ch14.18-UTC, Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), Aldesleukin (IL-2), Isotretinoin, 13-cis-retinoic acid
United Therapeutics
Neuroblastoma
06/14
06/14

Download Options